What is the recommended treatment for otitis media?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acute Otitis Media

Immediate Management Decision

For children under 6 months, those with severe symptoms (moderate-to-severe otalgia >48 hours or fever ≥39°C/102.2°F), or bilateral AOM in children 6-23 months, prescribe antibiotics immediately. 1, 2 For children 6-23 months with unilateral, non-severe AOM, or children ≥24 months with non-severe AOM (bilateral or unilateral), observation with close follow-up is an acceptable alternative based on shared decision-making with parents. 1, 2

Observation requires a reliable mechanism to ensure follow-up within 48-72 hours and immediate antibiotic availability if symptoms worsen or fail to improve. 2

Pain Management

Address pain immediately in every patient, regardless of whether antibiotics are prescribed—this is paramount and should occur within the first 24 hours. 1, 2 Use acetaminophen or ibuprofen as first-line analgesics. 2 Topical analgesics may provide relief within 10-30 minutes, though evidence quality is limited. 2

First-Line Antibiotic Selection

Prescribe high-dose amoxicillin (80-90 mg/kg/day divided into 2 doses) as the first-line antibiotic for most patients with AOM. 1, 2, 3 This recommendation is based on amoxicillin's effectiveness against common pathogens (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis), excellent safety profile, low cost, acceptable taste, and narrow microbiologic spectrum. 2, 3

When to Use Amoxicillin-Clavulanate Instead

Switch to amoxicillin-clavulanate (90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day of clavulanate in 2 divided doses) as first-line therapy in these specific situations: 1, 2, 4

  • Child received amoxicillin within the previous 30 days
  • Concurrent purulent conjunctivitis is present
  • History of recurrent AOM unresponsive to amoxicillin
  • Need for β-lactamase coverage (increasing prevalence of β-lactamase-producing H. influenzae and M. catarrhalis) 2

Penicillin-Allergic Patients

For patients with penicillin allergy, alternative antibiotics include: 2

  • Cefdinir (14 mg/kg/day in 1-2 doses)
  • Cefuroxime (30 mg/kg/day in 2 doses)
  • Cefpodoxime (10 mg/kg/day in 2 doses)
  • Ceftriaxone (50 mg IM or IV daily for 1-3 days)

Cross-reactivity between penicillins and second/third-generation cephalosporins is lower than historically reported, making these cephalosporins generally safe for non-severe penicillin allergies. 2

Azithromycin (30 mg/kg as single dose or 10 mg/kg daily for 3 days) is an option but less preferred due to increasing resistance patterns. 5

Treatment Duration

The duration varies by age and severity: 2

  • Children <2 years or those with severe symptoms: 10-day course
  • Children 2-5 years with mild-to-moderate AOM: 7-day course is equally effective
  • Children ≥6 years with mild-to-moderate symptoms: 5-7 day course

Treatment Failure Protocol

If symptoms worsen or fail to improve within 48-72 hours, reassess the patient to confirm AOM diagnosis and exclude other causes of illness. 1, 2, 3

Antibiotic Switching Algorithm:

  • If initially on amoxicillin: Switch to amoxicillin-clavulanate 1, 2
  • If initially on amoxicillin-clavulanate or patient fails second-line therapy: Consider intramuscular ceftriaxone (50 mg/kg/day for 1-3 days, with 3-day course superior to 1-day regimen) 2
  • For multiple treatment failures: Consider tympanocentesis with culture and susceptibility testing 2

Post-Treatment Expectations

After successful antibiotic treatment, 60-70% of children have middle ear effusion at 2 weeks, decreasing to 40% at 1 month and 10-25% at 3 months. 2 This persistent effusion without acute symptoms is otitis media with effusion (OME), which requires monitoring but not antibiotics. 2

Prevention Strategies

Modifiable risk factors to address include: 2

  • Encourage breastfeeding for at least 6 months
  • Reduce or eliminate pacifier use after 6 months of age
  • Avoid supine bottle feeding
  • Minimize daycare attendance when possible
  • Eliminate tobacco smoke exposure
  • Ensure pneumococcal conjugate vaccine (PCV-13) and annual influenza vaccination 1, 2

Long-term prophylactic antibiotics are discouraged for recurrent AOM. 1, 2

Critical Pitfalls to Avoid

  • Do not misdiagnose OME as AOM—this leads to unnecessary antibiotic use. 3 AOM requires acute onset, middle ear effusion, AND signs of acute inflammation. 1, 3
  • Do not use corticosteroids (systemic or intranasal) for routine AOM treatment—current evidence does not support their effectiveness. 2
  • Do not assume antibiotics prevent complications—33-81% of acute mastoiditis patients had received prior antibiotics. 2
  • Do not use ototoxic topical preparations when tympanic membrane integrity is uncertain or perforation is present. 2

Recurrent AOM Considerations

For children with recurrent AOM despite medical management, consider tympanostomy tube placement, which reduces recurrence rates (failure rates: 21% for tubes alone, 16% for tubes with adenoidectomy). 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Acute Otitis Media

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Otitis media: diagnosis and treatment.

American family physician, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.